JOHNSON & JOHNSON

We're making a few trades in the portfolio Friday, selling a less favored name to buy higher quality stocks.

The high grading of our portfolio continued Wednesday morning, with the moves made on American Eagle Outfitters and Johnson & Johnson.

After calling up a handful of names, we want to refresh a company already in our Bullpen, in addition to putting another one on it.

Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.

J&J announced in November that it would sheer off the consumer health business from its faster-growing medical devices and pharmaceutical portfolios.

Cross-contamination of coronavirus vaccines being made for Johnson & Johnson and AstraZeneca was discovered in March 2021. The company had more than $1.3 billion worth of contracts from the federal government and from Johnson & Johnson and AstraZeneca to make the vaccines. The hold tags indicated a potential quality problem with the vaccine in the containers, the House panel found. After discovery of cross-contamination, the Biden administration suspended the plant’s production of the Johnson & Johnson vaccine in April and permanently halted production of the AstraZeneca vaccine at the plant. But even after the restart in August, problems continued, according to the House report.

The suit seeks punitive damages, calls for a hospital, mental health and education programs, as well as a Tulsa Massacre Victims Compensation Fund.

These are the stocks posting the largest moves in midday trading.

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.

Johnson & Johnson on Tuesday lowered its full-year sales and earnings outlook, and stopped providing Covid-19 vaccine sales guidance due to a global supply surplus and demand uncertainty. J&J is now forecasting 2022 sales of $94.8 billion to $95.8 billion, about one billion dollars lower than the guidance provided in January. J&J reported first-quarter sales of $23.4 billion, slightly missing Wall Street expectations but growing 5% over the same quarter last year. The company's medical devices business grew by 5.9% to $6.97 billion in sales compared to the first quarter of 2021. "Looking ahead, I remain confident in the future of Johnson & Johnson as we continue advancing our portfolio and innovative pipeline."

Stock futures moved higher early Tuesday morning after stocks slipped during regular trading hours on Monday.

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths.

An appeals court judge found that the company made misleading and potentially harmful statements in advertisements and instructional brochures.

A California appeals court has upheld a lower court ruling that Johnson & Johnson must pay $302 million in penalties to the state for deceptively marketing pelvic mesh implants for women.

A trial on whether pharmacy chain Walgreens bears responsibility for the opioid crisis started Monday in Florida on the heels of opening statements last week in another opioid trial in West Virginia.

Lawyers for the state of West Virginia are concluding the first week of a trial against three major opioid makers.

Companies that aren't bankrupt are using controversial maneuvers in U.S. bankruptcy court to block tens of thousands of suits. A woman suing Johnson & Johnson died while her case was in legal limbo.

Johnson & Johnson's new CEO Joaquin Duato says in his first interview that AI in medicine will lead to innovations including real-time surgery decisions.

"It's not enough, but it's a good start," one lawyer said of settlement to fund local treatment and education efforts.

A federal judge has allowed a Johnson & Johnson spinoff to proceed with a controversial bankruptcy, despite complaints from thousands who say they were harmed by the company's baby powder.

The companies, including Johnson & Johnson and McKesson, will admit no wrongdoing. Billions of dollars in payouts will fund drug treatment and harm reduction programs.

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the opioid addiction crisis.

Analysis finds "unexpected levels" of human carcinogen coming from propellant that sprays product out of the can.

Moderna dropped more than 12%, the biggest decline in the S&P 500 as of Monday afternoon.

Drugmaker reportedly closed the Dutch plant that was making the vaccine in order to focus on a different drug.

Drugmaker reportedly closed the Dutch plant that was making the vaccine in order to focus on a different drug.

The only Johnson & Johnson facility making usable batches of the company's Covid vaccine has temporarily halted its production, The New York Times reported.

Money that will flow to Native American tribes as part of an opioid drug settlement with a major manufacturer and three distributors won't come quickly.

All federally recognized tribes in the U.S. will be able to participate in the settlements, even if they did not sue over opioids.

Johnson & Johnson, AmerisourceBergen, McKesson and Cardinal Health will pay $590 million to Native American tribes under a proposed settlement for the companies' role in the opioid crisis.

Landmark legal settlement offers "measure of justice" to Native American communities hit by opioid epidemic.

Native American tribes have reached opioid settlements worth over a half-billion dollars with drugmaker Johnson & Johnson and three distributors.

The Czech Republic has recorded a significant decline in people dying of COVID-19 despite facing a record number of infected in one month.

Denmark is scraping most pandemic restrictions as the country no longer considers COVID-19 to be “a socially critical disease.”.

Novavax's shots are based on a kind of "protein subunit" technology that has been used for decades in other routine vaccinations.

Novavax's shots are based on a kind of "protein subunit" technology that has been used for decades in other routine vaccinations.

The stocks making the biggest moves in premarket trading include 3M, Johnson & Johnson, General Electric and more.

Johnson & Johnson on Tuesday projected that its Covid vaccine would generate $3 billion to $3.5 billion in sales in 2022, after posting a mixed fourth-quarter report that slightly beat on earnings' estimates but missed on revenue. Revenue: $24.8 billion, vs. $25.29 billion expectedCFO Joseph Wolk told CNBC a strengthening dollar negatively impacted top line sales by $150 million to $200 million. Hospital staffing shortages caused by the omicron Covid variant also generated uncertainty in the company's medical devices business, particularly with elective procedures, Wolk said. J&J reported $93.77 billion in sales in 2021, a 13.6% increase over the prior year. J&J said it expects to generate $10.40 to $10.60 in earnings per share this year and $98.9 billion to $100.4 billion in revenue.

Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the health care giant’s COVID-19 vaccine gained momentum as well.

The Wisconsin senator said a "standard gargle" of mouthwash "has been proven to kill the coronavirus" or may reduce viral replication.

Wall Street analysts say Johnson & Johnson's decision to spin off its consumer division is overall a smart business move but it could come with some risks.

Two studies that have not yet been peer reviewed indicate increased protection against the infectious omicron variant.

Insider's Conflicted Congress project revealed Greene holds AstraZeneca, Pfizer, and Johnson & Johnson stock, each worth between $1,000 and $15,000.

Metro Health pop-up clinic takes place from 10 a.m. to 5 p.m., Wednesday

More than half a dozen recalls have been issued this year as carcinogen is also found in sunscreens, foot deodorants.

Oregon is on the verge of signing onto a $26 billion settlement with the three largest distributors of opioids and drugmaker Johnson & Johnson after being one of the latest holdout states to join.

South African President Cyril Ramaphosa has returned to work following a week of isolation after testing positive for COVID-19

These are the stocks posting the largest moves in midday trading.

Though reported Omicron cases have so far been mild, experts advise that every precaution should be taken to prevent infection.

The U.S. Centers for Disease Control and Prevention said on Thursday it had received reports of eight cases of myocarditis, a type of heart inflammation, in children aged 5-11 years who received Pfizer and BioNTech's COVID-19 vaccine.

The Advisory Committee on Immunization Practices voted unanimously to recommend Pfizer and Moderna over the Johnson & Johnson vaccine. Seventeen men developed TTS. A week later, the FDA and the CDC lifted the pause on J&J shots after the independent advisory panel said the benefits of the shots outweighed the risks. In October, the FDA and CDC authorized J&J boosters for all adults at least two months after receiving their initial J&J shot. People who received their primary vaccination with the J&J shot can also get boosted with the Pfizer or Moderna vaccines.

U.S. health officials say most Americans should get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot.

The European Union drugs regulator said Wednesday that people 18 and older can receive a booster shot for the Johnson & Johnson COVID-19 vaccine at least two months after their initial shot of the one-dose vaccine.

Mississippi alleges the consumer products giant failed to warn users of "potentially lethal" health risks.

The Supreme Court has turned away a request by Johnson & Johnson to halt a Mississippi lawsuit over its talcum power products.

The U.N.-led initiative is now aiming for 800 million doses to be delivered by the end of the year, but that isn't assured.

Johnson said a "standard gargle" of mouthwash "has been proven to kill the coronavirus" or may reduce viral replication.

Moderna president said current COVID-19 vaccines probably aren't effective against the new variant.

Moderna president said current COVID-19 vaccines probably aren't effective against the new variant.

Moderna president said current COVID-19 vaccines probably aren't effective against the new variant.

Some people are unboosted. Others mixed and matched the brands of their shots. Which differences matter?

The term “fully vaccinated” when it comes to COVID-19 means getting two jabs of...

A new coronavirus variant, first discovered in South Africa, has begun to spread around the globe. Vaccine producers say they're working to get ahead of the new strain.

Pfizer and BioNTech said they expect more data from lab tests in two weeks at the latest.

The full authorization makes Canada the first country to do so for Johnson & Johnson's COVID vaccine.

Are you one of the many Americans invested in GE or Johnson & Johnson? Here's what you need to know about their upcoming moves, according to experts.

Bexar County residents who have an opioid addiction will soon have more resources available to help them after the county approved a roughly $12 million portion of a settlement between the State of Texas and Johnson & Johnson worth more than $290 million.

Washington Attorney General Bob Ferguson has taken the state’s case against the nation’s three biggest drug distributors to trial.

Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine from its medical device and prescription drug business.

The Czech government is requiring children to get tested for COVID-19 as part of efforts to curtail a recent steep rise in cases.

The Oklahoma Supreme Court has overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state’s public nuisance law.

The NBA has told its players, coaches and referees that they should receive booster shots against the coronavirus, with particular urgency for those who received the single-dose Johnson & Johnson vaccine.

Top drug manufacturers have won a round in a California lawsuit that blamed them for the opioid crisis and sought billions of dollars to cover the costs of dealing with it.

A California judge has ruled for top drug manufacturers as local governments seek billions of dollars to cover their costs from the nation’s opioid epidemic.

The vaccine’s protection goes down with time, so medical experts recommend a supplemental dose after two to six months. Find out here if it’s time to get one.

The Food and Drug Administration is enforcing new warnings on breast implants.

Metro Health will administer COVID-19 booster doses of the Moderna and Johnson & Johnson vaccines beginning Wednesday at its COVID-19 vaccine pop-up clinics.

Asian stock markets are higher after Wall Street rose for a fifth day on strong corporate earnings.

Sales of the cancer treatment Darzalex helped Johnson & Johnson deliver better-than-expected third quarter earnings, while COVID-19 fueled vaccine revenue and had more customers reaching for Tylenol.

Police departments that are requiring officers to be vaccinated against COVID-19 are running up against pockets of resistance across the U.S. Police unions and officers are pushing back by filing lawsuits to block the mandates.

A panel of U.S. health advisers has endorsed booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine.

The Food and Drug Administration is wrestling with how to decide on booster doses of the single-shot Johnson & Johnson COVID-19 vaccine.

COVID-19 test kit maker Ellume is recalling some at-home tests after learning that they were reporting a higher-than-expected rate of false positive results.

Johnson & Johnson has asked U.S. regulators to allow booster shots of its COVID-19 vaccine as the U.S. government moves toward shoring up protection in more vaccinated Americans.

People who got a two-dose vaccine or one dose of the Johnson & Johnson shot are considered fully vaccinated — even without a booster.

Police in Slovenia have fired tear gas and water cannons at thousands of protesters who are against tough anti-coronavirus measures in the small European nation.

The state and its political subdivisions could get up to $1.5 billion from the settlement. But some local governments are considering pursuing their own lawsuits against drug makers and distributors.

Johnson & Johnson says a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose.

The World Health Organization and its partners hope to provide Africa with about 30% of the COVID-19 vaccines the continent needs by February.

Four companies say they'll move ahead with a $26 billion settlement of lawsuits over the opioid crisis.

Vaccine doses produced by a plant in South Africa will no longer be exported to Europe after the intervention of South Africa’s government, the African Union’s COVID-19 vaccine envoy said Thursday.

Johnson & Johnson says its potential HIV vaccine did not provide protection against the virus in a study of young women in sub-Saharan Africa.

South Africa will this weekend receive 2.2 million Pfizer-BioNTech vaccine doses donated by the United States to add to the 5.6 million doses it received from the U.S. in July.

Pfizer’s COVID-19 vaccine has been given the Food and Drug Administration's full approval, meaning it has now undergone the same rigorous regulatory review as dozens of other established vaccines.

Johnson & Johnson will replace Chairman and CEO Alex Gorsky with another veteran company executive starting next year.

The U.S. is planning booster doses of the Pfizer and Moderna COVID-19 vaccines, but if you got the one-dose Johnson & Johnson shot instead, stay tuned.

Health activists in Africa have slammed Johnson & Johnson for exporting vaccines produced in South Africa to countries in Europe, which have already immunized a large proportion of their populations and often have a surplus of vaccines.

Thousands of new coronavirus cases have been reported in West Africa in recent weeks amid low vaccination rates and the spread of the delta variant.

Millions of people in the U.S. who haven’t gotten the COVID-19 vaccine could soon have a new reason to roll up their sleeves: money in their pockets.

Hundreds of thousands of COVID-19 vaccine doses have been saved from the trash after U.S. regulators extended their expiration date for a second time.